Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Celltrion Inc.
DescriptionVaccine against H7N9 avian influenza virus
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationInfluenza virus
Indication DetailsVaccinate against H7N9 avian influenza virus
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today